Erratum {#Sec1}
=======

After the publication of this work \[[@CR1]\], a few points were brought to our attention:

The clinical data of patient 2 are incorrect. A revised version of Table [1](#Tab1){ref-type="table"} \[[@CR1]\] showing the corrected patient characteristics is presented here. Consequently, the description of the patient cohort in the Materials and Methods section is incorrect. The correct description is: "*Plasma miRNA analysis was performed on 18 HNSCC patients treated with local X-ray-irradiation using a linear accelerator \[...\].*Table 1**Patient characteristicsCharacteristicNumber of patients***Gender*  Male14  Female4*Median age, years*57.5*Age range, years*45.1--80.6*Tumor site*  Larynx5  Oropharynx3  Mouth floor2  Tongue2  Hypopharynx1  Maxilla1  Nasopharynx1  Sinuses1  Soft palate2*T-Stage*  I4  II3  III5  IV6*N-Stage*  N03  N14  N211*M-Stage*  M017  M11*Concomitant therapy (in addition to radiotherapy)*  5-FU + MMC13 (patient 2, 3, 5--7, 9--13, 15--17)  MMC3 (patient 1, 14, 18)  Cisplatin1 (patient 8)  Cetuximab1 (patient 4)*Acute toxicity*  Severe12  Moderate5  n.a.15-FU = 5-fluorouracil; MMC = mitomycin C; n.a. = not available.

*17 out of 18 patients received concurrent chemotherapy (13 patients received 5-fluorouracil (5-FU) plus mitomycin C (MMC) \[21\], 3 patients MMC and 1 patient cisplatin weekly)".*

There is a typing error in the Results section \[[@CR1]\] concerning the p value of the up-regulation of *miR-425-5p*. The correct sentence is:

*"The qRTPCR assays confirmed an up-regulation of miR-425-5p with a p value close to the significance level (p = 0.052) \[...\]".*

The corrections do not affect any results or conclusions of the published work.

The online version of the original article can be found under doi:10.1186/1748-717X-8-296.
